← SynDRA
MK-0812
SynDRA canonical compound SYN0038071 — structure-anchored drug synonym record
| Clinical phase | Phase 2 |
|---|
| Primary target(s) | CCR2 |
|---|
| Mechanism of action | CCK receptor antagonist |
|---|
All known targets
Mechanisms of action (all sources)
- CCK receptor antagonist
- CCR2 ANTAGONIST
- C-C chemokine receptor type 2 antagonist
- CC chemokine receptor antagonist
Cross-references
Synonyms
- Mk0812
- C-6448
- MK-812
- CCR2 antagonist (rheumatoid arthritis/multiple sclerosis), Merck
- MK0812
- C24H34F3N3O3
- MTMDXAIUENDNDL-RJSMDTJLSA-N
- MFCD11977737
- GTPL9048
- orb1679026
- SCHEMBL2209755
- SCHEMBL30046631
- EX-A939
- GLXC-90281
- BDBM50077906
- AKOS025401941
- CS-0344
- FM32516
- NCGC00378765-02
- NCGC00378765-03
- NCGC00378765-04
- NCGC00378765-05
- AC-27464
- AS-32918
- HY-50669
- BRD-K14175878-001-01-6
- Tox21_300263
- CAS-851916-42-2
- DSSTox_GSID_47335
- AKOS032944982
- MS-30497
- T16091
- HY-50669A
- DTXCID2027335
- MK-0812 (Succinate)
- MK-0812 Succinate
- NCGC00254109-01
- BM183631
Look up MK-0812 in the interactive SynDRA portal →